The interleukin 10-819C/T polymorphism and cancer risk: A HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls

OMICS A Journal of Integrative Biology

Volumn 17, Issue 4, 2013, Pages 200-214

  Yu, Zhibin ^a   Liu, Qing ^b   Huang, Chen ^a,c   Wu, Minghua ^a,b   Li, Guiyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b The Center for Skull Base Surgery and Neurooncology   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ALLELE; ASIA; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; DISEASE ASSOCIATION; DNA POLYMORPHISM; ETHNICITY; GENETIC LINKAGE; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHOMA; MELANOMA; META ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER;

ALLELES; CASE-CONTROL STUDIES; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK;

EID: 84876148067     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2012.0089     Document Type: Review

References (101)

1. Ahirwar D, Mandhani A, and Mittal RD. (2009). Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer. Arch Med Res 40, 97-102.
2. Alonso R, Suarez A, Castro P, Lacave AJ, and Gutierrez C. (2005). Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease. Melanoma Res 15, 53-60. (Pubitemid 40354474)
3. Alpizar-Alpizar W, Perez-Perez GI, Une C, Cuenca P, and Sierra R. (2005). Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin Exp Med 5, 169-176. (Pubitemid 41813760)
4. Amirzargar AA, Bagheri M, Ghavamzadeh A, et al. (2005). Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 32, 167-171. (Pubitemid 40768933)
5. Ando T, Ishikawa T, Kato H, et al. (2009). Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection. Int J Cancer 125, 2595-2602.
6. Basturk B, Yavascaoglu I, Vuruskan H, Goral G, Oktay B, and Oral HB. (2005). Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma. Cytokine 30, 41-45. (Pubitemid 40387354)
7. Bei CH, Chou XQ, Ceng XY, Yang Y, Huang JM, and Fan XJ. (2011). [Association of interleukin-10 gene polymorphism with hepatocellular carcinoma]. Zhong Guo Gong Gong Wei Sheng 27, 309-311.
8. Bushley AW, Ferrell R, Mcduffie K, Terada KY, Carney ME, Thompson PJ, et al. (2004). Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol 95, 672-679. (Pubitemid 39592536)
9. Cacev T, Radosevic S, Krizanac S, and Kapitanovic S. (2008). Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29, 1572-1580.
10. Castro Fa, Haimila K, Sareneva I, et al. (2009). Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population-A candidate gene approach. Int J Cancer 125, 1851-1858.
11. Chen KF, Li B, Wei YG, and Peng CJ. (2010). Interleukin-10-819 promoter polymorphism associated with gastric cancer among Asians. J Int Med Res 38, 1-8.
12. Chow MT, Moller A, and Smyth MJ. (2012). Inflammation and immune surveillance in cancer. Semin Cancer Biol 22, 23-32.
13. Colakogullari M, Ulukaya E, Yilmaztepe Oral A, et al. (2008). The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients. Cell Biochem Funct 26, 283-290. (Pubitemid 351613166)
14. Coussens LM, and Werb Z. (2002). Inflammation and cancer. Nature 420, 860-867. (Pubitemid 36019639)
15. Cozar JM, Romero JM, Aptsiauri N, et al. (2007). High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum Immunol 68, 698-704. (Pubitemid 47126657)
16. Crivello A, Giacalone A, Vaglica M, et al. (2006). Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma. Ann NY Acad Sci 1089, 98-103. (Pubitemid 47092057)
17. Crusius JB, Canzian F, Capella G, et al. (2008). Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol 19, 1894-1902.
18. Da Silva GN, Bacchi MM, Rainho CA, and De Oliveira DE. (2007). Epstein-Barr virus infection and single nucleotide polymorphisms in the promoter region of interleukin 10 gene in patients with Hodgkin lymphoma. Arch Pathol Lab Med 131, 1691-1696. (Pubitemid 350077467)
19. De Oliveira WR, Rady PL, Grady J, et al. (2003). Polymorphisms of the interleukin 10 gene promoter in patients from Brazil with epidermodysplasia verruciformis. J Am Acad Dermatol 49, 639-643. (Pubitemid 37210276)
20. De Visser KE, Eichten A, and Coussens LM. (2006). Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6, 24-37. (Pubitemid 43053650)
21. Dersimonian R, and Laird N. (1986). Meta-analysis in clinical trials. Control Clin Trials 7, 177-188. (Pubitemid 17189972)
22. Eder T, Mayer R, Langsenlehner U, et al. (2007). Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: A population-based study. Eur J Cancer 43, 472-475. (Pubitemid 46177585)
23. El-Omar EM, Rabkin CS, Gammon MD, et al. (2003). Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124, 1193-1201. (Pubitemid 36531795)
24. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, and Huizinga TW. (1998). Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 95, 9465-9470. (Pubitemid 28506254)
25. Faupel-Badger JM, Kidd LC, Albanes D, Virtamo J, Woodson K, and Tangrea JA. (2008). Association of IL-10 polymorphisms with prostate cancer risk and grade of disease. Cancer Causes Control 19, 119-124.
26. Festa F, Kumar R, Sanyal S, et al. (2005). Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism. Mutat Res 574, 105-111. (Pubitemid 40725972)
27. Fillatreau S, Gray D, and Anderton SM. (2008). Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol 8, 391-397. (Pubitemid 351595221)
28. Gonullu G, Basturk B, Evrensel T, Oral B, Gozkaman A, and Manavoglu O. (2007). Association of breast cancer and cytokine gene polymorphism in Turkish women. Saudi Med J 28, 1728-1733. (Pubitemid 350244364)
29. Grivennikov SI, Greten FR, and Karin M. (2010). Immunity, inflammation, and cancer. Cell 140, 883-899.
30. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, and Rothman N. (2006). Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15, 1126-1131.
31. Guzowski D, Chandrasekaran A, Gawel C, et al. (2005). Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. J Biomol Tech 16, 154-166.
32. He XP, Wang LL, Zhao H, Wu D, Tang HD, and Cao FL. (2008). [Association of interleukin-10 polymorphisms with susceptibility to ovarian cancer in Chinese Han population.]. Zhong Guo You Sheng Yu Yi Chuan Za Zhi 16, 37-38.
33. Hellmig S, Bartscht T, Fischbach W, Folsch UR, and Schreiber S. (2008). Interleukin-10 (-819 C/T) and TNF-A (-308 G/A) as risk factors for H. pylori-associated gastric MALT-lymphoma. Dig Dis Sci 53, 2007-2008.
34. Higgins JP, Thompson SG, Deeks JJ, and Altman DG. (2003). Measuring inconsistency in meta-analyses. BMJ 327, 557-560. (Pubitemid 37088507)
35. Howell WM, Turner SJ, Bateman AA, and Theaker JM. (2001). IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma. Genes Immun 2, 25-31. (Pubitemid 33674866)
36. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, and Houlston RS. (2007). Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial. Int J Cancer 121, 2001-2004. (Pubitemid 47463163)
37. Ioana Braicu E, Mustea A, Toliat MR, et al. (2007). Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: Results of a prospective study with 147 patients. Gynecol Oncol 104, 680-685. (Pubitemid 46240260)
38. Ioannidis JP, Boffetta P, Little J, et al. (2008). Assessment of cumulative evidence on genetic associations: Interim guidelines. Int J Epidemiol 37, 120-132. (Pubitemid 351228620)
39. Ioannidis JP, Patsopoulos NA, and Evangelou E. (2007). Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335, 914-916. (Pubitemid 350076978)
40. Kamangar F, Abnet CC, Hutchinson AA, et al. (2006). Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 17, 117-125. (Pubitemid 43084810)
41. Kang JM, Kim N, Lee DH, et al. (2009). The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pyloriinduced gastroduodenal diseases in Korea. J Clin Gastroenterol 43, 420-428.
42. Kesarwani P, Ahirwar DK, Mandhani A, et al. (2009). IL-10-1082 G A: A risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort. World J Urol 27, 389-396.
43. Kim J, Cho YA, Choi IJ, et al. (2012). Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer. PLoS One 7.
44. Kong F, Liu J, Liu Y, Song B, Wang H, and Liu W. (2010). Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population. J Exp Clin Cancer Res 29, 72.
45. Lan Q, Zheng T, Rothman N, et al. (2006). Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 107, 4101-4108. (Pubitemid 43726819)
46. Langsenlehner U, Krippl P, Renner W, et al. (2005). Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat 90, 113-115. (Pubitemid 40568894)
47. Lech-Maranda E, Baseggio L, Charlot C, et al. (2007). Genetic polymorphisms in the proximal IL-10 promoter and susceptibility to non-Hodgkin lymphoma. Leuk Lymphoma 48, 2235-2238. (Pubitemid 350091067)
48. Lee JY, Kim HY, Kim KH, et al. (2005). Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett 225, 207-214.
49. Leon A, Leon V, Garcia J, and Urrutia M. (2010). Interleukin gene polymorphism in patients with prostate cancer. Tissue Antigens 75, 637.
50. Liang L, Zhao YL, Yue J, et al. (2011). Interleukin-10 gene promoter polymorphisms and their protein production in pleural fluid in patients with tuberculosis. FEMS Immunol Med Microbiol 62, 84-90.
51. Liu J, Song B, Bai X, et al. (2010a). Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese. BMC Cancer 10, 456.
52. Liu J, Song B, Wang JL, Li ZJ, Li WH, and Wang ZH. (2011). Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. World J Gastroenterol 17, 1362-1367.
53. Liu JJ, Gao YT, Du Z, et al. (2010b). Relationship between IL-10 gene promoter polymorphisms and outcome of hepatitis B virus infection. World Chin J Digestol 18, 1656-1663.
54. Macarthur M, Sharp L, Hold GL, Little J, and El-Omar EM. (2005). The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol Biomarkers Prev 14, 1613-1618. (Pubitemid 40995069)
55. Martinez-Escribano JA, Moya-Quiles MR, Muro M, et al. (2002). Interleukin-10, interleukin-6 and interferon-gamma gene polymorphisms in melanoma patients. Melanoma Res 12, 465-469. (Pubitemid 35264723)
56. Mazur G, Bogunia-Kubik K, Wrobel T, et al. (2005). IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma. Immunol Lett 96, 241-246. (Pubitemid 39600781)
57. Michaud DS, Daugherty SE, Berndt SI, et al. (2006). Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res 66, 4525-4530.
58. Migita K, Miyazoe S, Maeda Y, et al. (2005). Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-Association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol 42, 505-510. (Pubitemid 40342929)
59. Moore KW, De Waal Malefyt R, Coffman RL, and O'garra A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683-765. (Pubitemid 32368050)
60. Munro LR, Johnston PW, Marshall NA, et al. (2003). Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma. Leuk Lymphoma 44, 2083-2088. (Pubitemid 37369648)
61. Nieters A, Yuan JM, Sun CL, et al. (2005). Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 103, 740-748. (Pubitemid 40216402)
62. O'garra A, and Vieira P. (2007). T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 7, 425-428. (Pubitemid 46834852)
63. Persson C, Canedo P, Machado JC, El-Omar EM, and Forman D. (2011). Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. Am J Epidemiol 173, 259-270.
64. Pharoah PD, Dunning AM, Ponder BA, and Easton DF. (2004). Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4, 850-860. (Pubitemid 39472952)
65. Pharoah PD, Tyrer J, Dunning AM, Easton DF, and Ponder BA. (2007). Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 3, e42.
66. Pogoda TV, Marsheva OV, Kostin PA, et al. (2007). Association of haplotypes of interleukin-10 gene with the risk of cancer. Bull Exp Biol Med 144, 385-389.
67. Pratesi C, Bortolin MT, Bidoli E, et al. (2006). Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 55, 23-30. (Pubitemid 41783289)
68. Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic Cm, Turner J, et al. (2007). Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: Findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 28, 704-712. (Pubitemid 46523368)
69. Roh JW, Kim MH, Seo SS, et al. (2002). Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett 184, 57-63. (Pubitemid 34718107)
70. Ryan JJ, Kashyap M, Bailey D, et al. (2007). Mast cell homeostasis: A fundamental aspect of allergic disease. Crit Rev Immunol 27, 15-32. (Pubitemid 46659045)
71. Savage SA, Abnet CC, Haque K, et al. (2004). Polymorphisms in interleukin-2,-6, and-10 are not associated with gastric cardia or esophageal cancer in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev 13, 1547-1549. (Pubitemid 39202326)
72. Seifart C, Plagens A, Dempfle A, et al. (2005). TNF-alpha, TNFbeta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers 21, 157-165. (Pubitemid 41566735)
73. Shao N, Xu B, Mi YY, and Hua LX. (2011). IL-10 polymorphisms and prostate cancer risk: A meta-analysis. Prostate Cancer Prostatic Dis 14, 129-135.
74. Shih CM, Lee YL, Chiou HL, et al. (2005). The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer 50, 291-297.
75. Shin HD, Park BL, Kim LH, et al. (2003). Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 12, 901-906. (Pubitemid 36504032)
76. Sicinschi LA, Lopez-Carrillo L, Camargo MC, et al. (2006). Gastric cancer risk in a Mexican population: Role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and-10 genes. Int J Cancer 118, 649-657. (Pubitemid 43076014)
77. Singh H, Jain M, Sachan R, and Mittal B. (2009). Association of TNFA (-308G A) and IL-10 (-819C T) promoter polymorphisms with risk of cervical cancer. Int J Gynecol Cancer 19, 1190-1194.
78. Spits H, and De Waal Malefyt R. (1992). Functional characterization of human IL-10. Int Arch Allergy Immunol 99, 8-15. (Pubitemid 23010347)
79. Sterne JA, Gavaghan D, and Egger M. (2000). Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature. J Clin Epidemiol 53, 1119-1129.
80. Su SP, Yang ZB, and Tian YL. (2010). Relationship between polymorphisms of IL-1(beta)-31, IL-10-819 and TNF-(alpha)-1031 genes and susceptibilities to H. pylori infection-associated gastric ulcer and cancer. Chin J Biol 23, 517-520.
81. Sugimoto M, Furuta T, Shirai N, et al. (2007). Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 22, 1443-1449. (Pubitemid 47274569)
82. Tseng LH, Lin MT, Shau WY, et al. (2006). Correlation of interleukin-10 gene haplotype with hepatocellular carcinoma in Taiwan. Tissue Antigens 67, 127-133.
83. Turner DMm, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, and Hutchinson IV. (1997). An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24, 1-8. (Pubitemid 27050850)
84. Vancleave TT, Moore JH, Benford ML, et al. (2010). Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate 70, 341-352.
85. Vishnoi M, Choudhuri G, and Mittal B. (2007). Is IL-10-819C/T gene polymorphism modulating the risk of gallbladder disease in North Indian population? J Gastrointest Cancer 38, 46-51.
86. Vogel U, Christensen J, Dybdahl M, et al. (2007). Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat Res 624, 88-100. (Pubitemid 47588301)
87. Vogel U, Christensen J, Wallin H, et al. (2008). Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res 639, 89-100.
88. Wang MH, Helzlsouer KJ, Smith MW, et al. (2009). Association of IL10 and other immune response-and obesity-related genes with prostate cancer in CLUE II. Prostate 69, 874-885.
89. Wei YG, Liu F, Li B, et al. (2011). Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: A metaanalysis. World J Gastroenterol 17, 3941-3947.
90. Wei YS, Kuang XH, Zhu YH, et al. (2007). Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma. Tissue Antigens 70, 12-17.
91. Williams LM, Ricchetti G, Sarma U, Smallie T, and Foxwell BM. (2004). Interleukin-10 suppression of myeloid cell activation-A continuing puzzle. Immunology 113, 281-292. (Pubitemid 39472144)
92. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, and Lin JT. (2003). Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 104, 617-623.
93. Xiao H, Li C, Jiang Y, Li R, and Xia B. (2009). [The relationship among IL-10, TNF gene polymorphisms, Helicobacter pylori infection and gastroduodenal diseases in Hubei Han ethnic]. Zhonghua Nei Ke Za Zhi 48, 552-556.
94. Xue H, Lin B, An J, Zhu Y, and Huang G. (2012). Interleukin-10-819 promoter polymorphism in association with gastric cancer risk. BMC Cancer 12, 102.
95. Yao JG, Gao LB, Liu YG, Li J, and Pang GF. (2008). Genetic variation in interleukin-10 gene and risk of oral cancer. Clin Chim Acta 388, 84-88. (Pubitemid 350266574)
96. Zabaleta J, Lin HY, Sierra RA, et al. (2008). Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis 29, 573-578. (Pubitemid 351404874)
97. Zambon CF, Basso D, Navaglia F, et al. (2005). Pro-and antiinflammatory cytokines gene polymorphisms and Helicobacter pylori infection: Interactions influence outcome. Cytokine 29, 141-152. (Pubitemid 40126232)
98. Zeng X, Li Y, Liu T, and Zhang J. (2012). Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China. Mol Cell Biochem 361, 241-248.
99. Zhang Z, Liu W, Jia X, Gao Y, Hemminki K, and Lindholm B. (2004). Use of pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma. Clin Chim Acta 342, 137-143. (Pubitemid 38352922)
100. Zoodsma M, Nolte IM, Schipper M, et al. (2005). Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease. Int J Gynecol Cancer 15 Suppl 3, 282-290. (Pubitemid 43096595)
101. Zou YF, Wang F, Feng XL, et al. (2011). Lack of association of IL-10 gene polymorphisms with prostate cancer: Evidence from 11,581 subjects. Eur J Cancer 47, 1072-1079.